Mitra Biotech Stock
personalized cancer treatment
Sign up today and learn more about Mitra Biotech Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Mitra Biotech Stock
Mitra is an innovative biotechnology company dedicated to discover tools to segregate patients for existing and developing anti-cancer treatments. Mitra is addressing significant challenges in personalized cancer medicine with dedicated scientists educated and trained in world famous institutes. Mitra’s discoveries to detect and manage cancer have practical applications and will be moved from the bench to bedside.
Investors
Funding History
April 2010 | $2.2M |
---|---|
October 2013 | $4.9M |
August 2016 | $27.4M |
July 2018 | $40.0M |
Management
Chief Commercial Officer
Parker Cassidy
Co-Founder & CSO
Pradip Majumder
Co-Founder, President & CEO
Mallik Sundaram
Press
einpresswire - Aug, 16 2023
Farcast announces ISO 9001 certification human Tumor Microdynamics (hTMD) platformlivemint - Jul, 28 2019
Behind the rise of deep tech healthcare startups in Bengalurulivemint - Jul, 28 2019
This cancer startup drew lessons from a refugee campfinsmes - Jul, 13 2018
Biotech Company Mitra RxDx Raises $40M in Financingprnewswire - Feb, 28 2018
Mitra Biotech Announces CAP Accreditation